Human Genome Epidemiology Literature Finder
Records 1 - 11 (of 11 Records) |
Query Trace: Ovarian Neoplasms and CYP1B1[original query] |
---|
Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001 Mar 10 (3): 209-16. Goodman MT, McDuffie K, Kolonel LN, Terada K, Donlon TA, Wilkens LR, Guo C, Le Marchand L |
Lack of association of CYP1 B1*3 polymorphism and ovarian cancer in a Caucasian population. The International journal of biological markers 0 19 (2): 160-3. Cecchin E, Russo A, Campagnutta E, Martella L, Toffoli |
Estrogen bioactivation, genetic polymorphisms, and ovarian cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Nov 14 (11 Pt 1): 2536-43. Sellers Thomas A, Schildkraut Joellen M, Pankratz V Shane, Vierkant Robert A, Fredericksen Zachary S, Olson Janet E, Cunningham Julie, Taylor William, Liebow Mark, McPherson Carol, Hartmann Lynn C, Pal Tuya, Adjei Araba |
Ovarian cancer risk and polymorphisms involved in estrogen catabolism. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007 Mar 16 (3): 481-9. Holt Sarah K, Rossing Mary Anne, Malone Kathleen E, Schwartz Stephen M, Weiss Noel S, Chen C |
Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007 Oct 25 (29): 4528-35. Marsh Sharon, Paul Jim, King Cristi R, Gifford Gillian, McLeod Howard L, Brown Robe |
Variant in sex hormone-binding globulin gene and the risk of prostate cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007 Jan 16 (1): 165-8. Berndt Sonja I, Chatterjee Nilanjan, Huang Wen-Yi, Chanock Stephen J, Welch Robert, Crawford E David, Hayes Richard |
Association between genetic polymorphisms and ovarian cancer risk. Anticancer research 0 28 (5B): 3079-81. Delort Laetitia, Chalabi Nasséra, Satih Samir, Rabiau Nadège, Kwiatkowski Fabrice, Bignon Yves-Jean, Bernard-Gallon Dominique |
Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer. Cancer research 2009 Mar 69 (5): 1877-84. Koutros Stella, Berndt Sonja I, Sinha Rashmi, Ma Xiaomei, Chatterjee Nilanjan, Alavanja Michael C R, Zheng Tongzhang, Huang Wen-Yi, Hayes Richard B, Cross Amanda |
Cytochrome P1B1 (CYP1B1) polymorphisms and ovarian cancer risk: a meta-analysis. Toxicology 2012 Sep . Gajjar K, Owens G, Sperrin M, Martin-Hirsch PL, Martin FL |
Association between the CYP1B1 polymorphisms and risk of cancer: a meta-analysis. Molecular genetics and genomics : MGG 2015 Apr 290 (2): 739-65. Liu Jie-Ying, Yang Yu, Liu Zhi-Zhong, Xie Jian-Jun, Du Ya-Ping, Wang W |
The ovarian carcinoma risk with the polymorphisms of CYP1B1 come from the positive selection. American journal of translational research 2021 13 (5): 4322-4341. Zhang Liying, Feng Liyuan, Lou Meng, Deng Xihan, Liu Chuanzhong, Li |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: